Verano Holdings (VRNO) Inventory (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Inventory of $235.6 million for Q1 2026, up 22.53% year-over-year from $192.3 million in Q1 2025, and up 2.44% quarter-over-quarter from $230.0 million in Q4 2025.
Verano Holdings (VRNO) Inventory (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Inventory for 6 consecutive years, with $235.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 22.53% year-over-year to $235.6 million; the TTM figure through Mar 2026 stood at $235.6 million (up 22.53% YoY), while the FY2025 annual figure was $230.0 million, up 24.67% from the prior year.
- Inventory advanced to $235.6 million in Q1 2026 per VRNO's latest filing, from $230.0 million in the prior quarter.
- Across five years, Inventory topped out at $235.6 million in Q1 2026 and bottomed at $3.9 million in Q1 2022.
- Historically, Inventory has averaged $170.7 million across 5 years, with a median of $168.1 million in 2022.
- Annual changes were most pronounced in 2022 — Inventory jumped 5261.09% — and 2023, when it retreated 10.3%.
- Verano Holdings' Inventory stood at $164.5 million in 2022, then declined by 5.33% to $155.8 million in 2023, then rose by 18.42% to $184.5 million in 2024, then gained by 24.67% to $230.0 million in 2025, then gained by 2.44% to $235.6 million in 2026.
- Business Quant data shows VRNO's Inventory at $235.6 million in Q1 2026, $230.0 million in Q4 2025, and $219.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 816.00 Mn |
| 10 | Verano Holdings | 441.74 Mn | 356.55 Mn | 99.70 Mn | 222.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.20 Mn |
| Mar 31, 2026 | 235.58 Mn |
| Dec 31, 2025 | 229.97 Mn |
| Sep 30, 2025 | 219.72 Mn |
| Jun 30, 2025 | 214.34 Mn |
| Mar 31, 2025 | 192.26 Mn |
| Dec 31, 2024 | 184.46 Mn |
| Sep 30, 2024 | 194.05 Mn |
| Jun 30, 2024 | 169.36 Mn |
| Mar 31, 2024 | 166.18 Mn |
| Dec 31, 2023 | 155.77 Mn |
| Sep 30, 2023 | 150.82 Mn |
| Jun 30, 2023 | 144.89 Mn |
| Mar 31, 2023 | 153.61 Mn |
| Dec 31, 2022 | 164.53 Mn |
| Sep 30, 2022 | 168.14 Mn |
| Jun 30, 2022 | 154.05 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 3.07 Mn |